October 15th, 2019 by Medgadget Editors
Venous thromboembolism (VTE) too often strikes bedridden patients in the hospital, and this is one of the main reasons that patients are put back on their feet as soon as possible. Inflatable wraps placed around the legs, which can raise the pressure, are a common way to prevent the condition. Now, a device called geko from Sky Medical Technology, a U.K. firm, has just been cleared by the FDA to stimulate the calf muscles, in turn increasing blood circulation, and helping to prevent VTE. The device was previously only cleared...Read More

October 15th, 2019 by Medgadget Editors
Electron microscopy revealed a world that exists at scales smaller than the wavelength of light. Advancements in this field have allowed scientists to visualize ever more objects and processes, but actually seeing living cells in 3D and within a liquid environment has been impossible. Now, a team of researchers from Penn State University, Virginia Tech, and a company called Protochips have developed a system that allows for an electron microscope to be used to volumetrically visualize living cells and biological systems that exist in a liquid. “With this technology that...Read More

October 15th, 2019 by Medgadget Editors
Most drugs, genetic materials, and other therapeutic agents are very difficult to use inside the brain because of the blood-brain barrier. There have been attempts to use ultrasound and microbubbles to create temporary passages through the barrier, including as a possible therapy for Alzheimer's disease, but this is approach is not easy or ideal. Now, researchers from Newcastle University in the U.K. have used a peptide (chain of amino acids) to create drug-loaded nanoparticles, about the size of viruses, that can autonomously cross the blood-brain barrier. The new particles can...Read More
Last year, Medgadget heard from Noble International about its "smart" training devices that educate patients on safe and effective at-home use of prefilled syringes and autoinjectors. At the time, Joe Reynolds, Research Manager at Noble International, shared some use cases for the company's products, including rheumatoid arthritis (RA). Since that interview, longitudinal data has proven the efficacy of Noble's training devices in clinical studies. All patients who practiced with the trainers at home for 14 days were able to complete all steps required to administer a self-injection without errors, compared...Read More

October 14th, 2019 by Conn Hastings
Researchers at Columbia University have developed a microfluidic device that can diagnose Lyme disease in as little as 15 minutes. The device is particularly accurate in identifying antibody biomarkers that are present during early stage Lyme disease, raising hopes that it could be useful in detecting cases of early infection in a doctor’s office, leading to timely treatment. Lyme disease, which is spread by infected ticks, is incredibly common. Approximately 300,000 Americans are diagnosed with the disease each year, and if left untreated it can result in serious neurological and...Read More
iRhythm and Verily announced a partnership last month to "co-develop solutions intended to provide early warning, diagnosis and management for patients, particularly for those with silent or undiagnosed AF." We spoke with iRhythm CEO Kevin King to understand how the two companies complement each other and how they can solve the problem together. Ben Ouyang, Medgadget: Tell us about yourself. Kevin King: I've been CEO of iRhythm now for seven years, since the very early days when our company was private. I’ve led the company's growth and expansion to where...Read More

October 11th, 2019 by Medgadget Editors
Carbon monoxide (CO) is one of the most common substances that people are poisoned by. It has no smell and is invisible to the naked eye, but can cause severe damage to tissues and lead to death. Patients who have already suffered significant lung damage because of CO inhalation too often don't respond sufficiently to pure oxygen. Now, researchers at Massachusetts General Hospital have shown that a new device that treats patient blood using visible light works better that standard of care oxygen therapy. The research, so far performed in...Read More

October 11th, 2019 by Medgadget Editors
Kids with autism can become unruly and aggressive, often without any warnings for those around them. Such outbursts can also be emotionally difficult for family and caretakers, not just the kids, and planning events and going into public places is a major challenge. Having a bit of warning about an autistic child's worsening mental state may help to mitigate and even prevent outbursts. Using the Q-Sensor wrist-worn monitor from Affectiva, a company based in Cambridge, Massachusetts, researchers at the University of Missouri have been able to identify increased electrodermal activity...Read More
Medtronic has filed for FDA approval for its InterStim Micro neurostimulator and the accompanying InterStim SureScan MRI leads. The rechargeable device delivers sacral neuromodulation therapy to treat conditions such as overactive bladder, fecal incontinence, unobstructed urinary retention, and urinary urge incontinence. Along with the InterStim Micro, the new leads allow patients with the implanted system to safely receive MRI scans, given certain precautions. Sacral stimulation involves modulating signals passed between the brain, bowel, and bladder, improving performance of the underlying muscles. Because the new implant is 80% smaller than the...Read More

October 10th, 2019 by Medgadget Editors
Modern clinical MRIs usually have magnetic field strengths of 1.5 or 3.0 Tesla. These are pretty powerful magnets and it's the reason that these devices are very expensive. While such strengths have been standard for a long time, the internal hardware and software beyond the magnets have been improving steadily. Now, researchers affiliated with the National Institutes of Health have worked with a team at Siemens to see what a modern MRI, operating at a lower strength, is capable of. It may make sense to build weaker MRIs in order...Read More

October 10th, 2019 by Medgadget Editors
Dexcom landed FDA clearance for its Dexcom G6 Pro continuous glucometry system. Intended to be used by medical professionals with their patients, it offers a novel "blinded" mode that allows physicians to hide live glucose readings from patients. Using this capability, doctors can review glucometry data and propose lifestyle changes to patients following an up-to 10 day test period. In the meantime, patients don't have to worry about what their glucometer is reading and so won't be making potentially dangerous decisions on their own. The blinded mode is optional and...Read More

« Older Entries




Emergency Medicine



Holler Box


Exclusive Medgadget news in your mailbox!

Your information will never be shared with any third party.